Logo image
IRO Home Research units Researcher Profiles
Sign in
Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infection
Journal article   Open access   Peer reviewed

Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infection

Jonathan A Trujillo, Erica L Fleming and Stanley Perlman
Journal of virology, Vol.87(5), pp.2376-2389
03/2013
DOI: 10.1128/JVI.03089-12
PMCID: PMC3571407
PMID: 23269787
url
https://europepmc.org/articles/pmc3571407View
Published (Version of record) Open Access

Abstract

Microglia - metabolism Brain - virology Coronavirus Infections - mortality Brain - metabolism CD4-Positive T-Lymphocytes - immunology Murine hepatitis virus - immunology CD40 Antigens - biosynthesis Inflammation - metabolism Microglia - immunology Doxorubicin - analogs & derivatives Chemokine CCL2 - metabolism Macrophages - immunology Forkhead Transcription Factors - biosynthesis Nitric Oxide - biosynthesis Mice, Inbred C57BL Chemokine CCL2 - genetics Mice, Transgenic Inflammation - immunology Coronavirus Infections - immunology Macrophage Activation Immunosuppression Macrophages - metabolism Animals B7-2 Antigen - biosynthesis Histocompatibility Antigens Class II - immunology Coronavirus Infections - virology Mice Histocompatibility Antigens Class II - genetics Brain - immunology Doxorubicin - biosynthesis

Details

Logo image